Issuance of Series A-1 Preferred Stock (Details) - USD ($)
|
|
|
|
1 Months Ended |
3 Months Ended |
|
|
|
Mar. 13, 2024 |
Jul. 11, 2023 |
Mar. 03, 2023 |
Jul. 31, 2021 |
Mar. 31, 2024 |
Dec. 31, 2023 |
Mar. 31, 2023 |
Dec. 31, 2022 |
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares authorized |
|
|
|
|
9,904,773
|
9,926,161
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
Conversion of shares description |
|
|
|
|
(i) shares of common stock of the Company and, if applicable, shares of Series A-2 Preferred
Stock, in lieu of common stock, (ii) a tranche A warrant to acquire approximately 46,675,940 shares (excluding deemed dividends) of Series
A-3 Preferred Stock (the “Tranche A Warrant”), (iii) a tranche B warrant to acquire approximately 42,432,672 shares (excluding
deemed dividends) of Series A-4 Preferred Stock (the “Tranche B Warrant”), and (iv) a tranche C warrant to acquire approximately
67,892,276 shares (excluding deemed dividends) of Series A-5 Preferred Stock (the “Tranche C Warrant”, together with the Tranche
A Warrant and the Tranche B Warrant, the “Warrants”). The Tranche A Warrant, for an aggregate exercise price of approximately
$25 million, is exercisable until 21 days following the Company’s announcement of receipt of FDA approval for Oxylanthanum Carbonate,
the Tranche B Warrant, for an aggregate exercise price of approximately $25 million, is exercisable until 21 days following the Company’s
announcement of receipt of Transitional Drug Add-On Payment Adjustment (“TDAPA”) approval for Oxylanthanum Carbonate, and
the Tranche C Warrant for an aggregate exercise price of approximately $50 million is exercisable until 21 days following four quarters
of commercial sales of Oxylanthanum Carbonate following receipt of TDAPA approval.
|
|
|
|
Aggregate fair value (in Dollars) |
|
|
|
|
$ 2,800,000
|
|
|
|
Initial carrying value (in Dollars) |
|
|
|
|
$ 25,400,000
|
|
|
|
Shares issued |
|
19,516,205
|
|
|
|
|
|
|
Auto-conversion preferred shares |
|
43,649
|
|
|
736,773
|
|
|
|
Common stock value (in Dollars) |
|
|
|
|
$ 1,000
|
|
|
|
Common stock voting rights |
|
|
|
|
one
|
|
|
|
Warrant [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
47,852,430
|
|
|
|
Aggregate offering price (in Dollars) |
|
|
|
|
|
|
$ 200,000
|
|
Shares issued |
|
|
|
4,000,000
|
|
|
|
|
Warrants exercise price (in Dollars per share) |
|
|
|
$ 6
|
$ 1,000
|
|
|
|
Amended Tranche B Warrants [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
25,666.30154
|
|
|
|
|
|
|
Original Tranche C Warrants [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
69,603,531
|
|
|
|
|
|
|
Amended Tranche C Warrants [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
51,506.61294
|
|
|
|
|
|
|
Series A-1 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
30,190
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
30,190
|
|
|
|
Number of share issued |
|
|
30,190
|
|
|
|
|
|
Aggregate net proceeds (in Dollars) |
|
|
$ 28,000,000
|
|
|
|
|
|
Agent fees and offering expenses (in Dollars) |
|
|
$ 2,200,000
|
|
|
|
|
|
Designated shares of preferred stock |
|
|
|
|
30,190
|
|
|
|
Aggregate offering price (in Dollars) |
|
|
|
|
$ 2,000,000
|
|
|
|
Series A-2 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares authorized |
|
|
|
|
21,388.01
|
43,649
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
19,991.51
|
43,649
|
|
|
Designated shares of preferred stock |
|
|
|
|
1,800,000
|
|
|
|
Series A-3 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Designated shares of preferred stock |
|
|
|
|
1,800,000
|
|
|
|
Series A-3 Preferred Stock [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
25,840.3122
|
|
|
|
|
|
|
Series A-4 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Designated shares of preferred stock |
|
|
|
|
1,800,000
|
|
|
|
Series A-4 Preferred Stock [Member] | Warrant [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
43,502,206
|
|
|
|
|
|
|
Series A-5 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Designated shares of preferred stock |
|
|
|
|
3,600,000
|
|
|
|
Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
$ 0.001
|
|
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Aggregate shares |
21,388.01
|
|
|
|
|
|
|
|
Stated par value (in Dollars) |
|
|
|
|
$ 1,000
|
|
|
|
Series A-2 Prime Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.49
|
|
|
|
Series A-2 Prime Convertible Preferred Stock [Member] | Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
0.49
|
|
|
|
Series A-3 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.54
|
|
|
|
Series A-3 Convertible Preferred Stock [Member] | Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
25,900
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.54
|
|
|
|
Series A-4 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.59
|
|
|
|
Series A-4 Convertible Preferred Stock [Member] | Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
25,700
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.59
|
|
|
|
Series A-5 Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.74
|
|
|
|
Series A-5 Convertible Preferred Stock [Member] | Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
51,600
|
|
|
|
Preferred stock conversion price (in Dollars per share) |
|
|
|
|
$ 0.74
|
|
|
|
Series A-2 Prime Preferred Stock [Member] | Exchange Agreement [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
21,400
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Stated par value (in Dollars) |
|
|
|
|
$ 1,000
|
|
|
|
Common stock voting rights |
|
|
|
|
one
|
|
|
|
Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares authorized |
|
|
|
|
|
|
|
10,000,000
|
Preferred stock, par value (in Dollars per share) |
|
|
|
|
|
|
|
$ 0.001
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
Shareholder [Member] | Series A-1 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
0
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
0
|
|
|
Shareholder [Member] | Series A-2 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
Issuance of Series A-1 Preferred Stock [Line Items] |
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
43,649
|
|
|
Preferred stock, shares outstanding |
|
|
|
|
|
43,649
|
|
|